Yi Ching Yau

Yi Ching Yau has served as our Chief Accounting Officer since October 2019. Prior to joining BridgeBio, Ms. Yau served as the Vice President of Finance at Nektar Therapeutics, Inc., starting in May 2018. From November 2013 to May 2018, Ms. Yau served as the Executive Director Corporate Controller of Theravance Biopharma, Inc. Prior to joining Theravance, Ms. Yau was an Assurance Senior Manager at Ernst & Young LLP from October 2003 to November 2013. She received her Bachelor of Accountancy from Nanyang Technological University in 1999.